Physician profile
Thomas W Wallace
NPI 1295807733
$13,777.11
in general payments reported to CMS, 2019-2025
28 companies · $642 in 2025
The $642 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,278 · 2020: $4,321 · 2021: $2,362 · 2022: $1,371 · 2023: $1,739 · 2024: $1,064 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,959 · Travel and Lodging: $399 · Education: $86.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,959.42 |
| Travel and Lodging | $399.31 |
| Education | $86.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $7,203.89 | 2019-2025 | Carto 3 |
| Medtronic, INC. | $1,603.82 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Selectsecure |
| Abbott Laboratories | $972.81 | 2019-2025 | Ensite, Aveir, Gallant |
| Medical Device Business Services, INC. | $922.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $674.52 | 2019-2025 | |
| Medtronic Vascular, INC. | $617.16 | 2019-2020 | |
| Boston Scientific Corporation | $290.67 | 2019-2024 | Watchman Access System |
| Atricure, INC. | $281.07 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $187.56 | 2022-2025 | Camzyos, Eliquis |
| Altathera Pharmaceuticals LLC | $145.46 | 2023 | Sotalol Hydrochloride |
| Sanofi-Aventis U.S. LLC | $98.87 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $80.90 | 2019-2022 | |
| Irhythm Technologies, INC. | $80.65 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $71.35 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.00 | 2020-2023 | Lifevest |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $60.84 | 2019-2023 | Repatha |
| Cordis US Corp. | $58.95 | 2024 | Mynx Venous Vcd |
| Elutia, INC. | $52.54 | 2020-2022 | |
| United Therapeutics Corporation | $45.95 | 2024-2025 | Tyvaso, Tyvaso |
| Philips North America LLC | $43.69 | 2022-2025 | Lm Undivided, (Ck4) Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.92 | 2019-2020 | |
| Shockwave Medical, INC | $37.08 | 2022 | |
| Alnylam Pharmaceuticals INC. | $32.12 | 2024-2025 | Amvuttra |
| Cvrx, INC. | $29.81 | 2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $26.42 | 2020-2021 | |
| Baxter Healthcare | $22.13 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Cardiva Medical, INC. | $21.09 | 2021 | |
| Cardiovascular Systems INC. | $15.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.